Analysed ARS Pharmaceuticals Inc (SPRY:NASDAQ) News Sources
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
Markets Insider
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year ...
The Bakersfield Californian
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥ ...
The Globe and Mail
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
The Oklahoman
What is the current price of ARS Pharmaceuticals Inc (SPRY:NASDAQ)?
The current price of ARS Pharmaceuticals Inc (SPRY:NASDAQ) is $9.06.
ARS Pharmaceuticals Inc (SPRY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARS Pharmaceuticals Inc (SPRY:NASDAQ) since the previous trading day is $-0.18.
ARS Pharmaceuticals Inc (SPRY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARS Pharmaceuticals Inc (SPRY:NASDAQ) since the previous trading day is -1.95%.
What is This Week's average sentiment score for ARS Pharmaceuticals Inc (SPRY:NASDAQ)?
This Week's average sentiment score for ARS Pharmaceuticals Inc (SPRY:NASDAQ) is 72 out of 100.
What is This Week's average sentiment for ARS Pharmaceuticals Inc (SPRY:NASDAQ)?
This Week's sentiment for ARS Pharmaceuticals Inc (SPRY:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.